Brazil ABIMO welcomes launch of Criatec seed capital investment fund
This article was originally published in Clinica
Brazil's national development bank (BNDES) has launched Criatec, a seed capital investment fund aimed at early-stage and start-up companies. Project proposals to Criatec can be submitted online, according to an alert posted by medtech industry association ABIMO/Sinaemo, at www.fundocriatec.com.br/acelere.php (via the link "Envio de oportunidade").
You may also be interested in...
Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.
Sawai’s sales increased on the back of a good performance from recently-launched products in the first nine months of its financial year. However, given the competitive environment the Japanese company is continuing to stick to its full-year forecasts.